You are here

Model-informed Drug Discovery and Development in Cardiac Safety

Jan 18 to Jan 22
, 2016


Sweden

This Pharma lead DDMoRe course in Cardiac Safety evaluation is one in a series of comprehensive face-to-face courses introducing the principles of model-informed drug discovery and development, covering a range of therapeutic areas, via the newly-developed DDMoRe interoperability framework.

The Department of Quantitative Clinical Pharmacology, AstraZeneca R&D Gothenburg, Sweden together with the Institute of Pharmacy, Freie Universitaet Berlin, Germany are happy to invite you to the following face-to-face course:

Model-informed Drug Development in Cardiac Safety

Apply here

Work package: 

Associated members

Academia
Charlotte Kloft's picture
Charlotte Kloft
Freie Universität Berlin - FUB
Zinnia Parra-Guillén's picture
Zinnia Parra-Guillén
UNAV
EFPIA
S. Y. Amy Cheung's picture
S. Y. Amy Cheung
AstraZeneca

Related links

AAPS - American Association of Pharmaceutical Scientists

ACoP - American Conference on Pharmacometrics

COMBINE - The 'COmputational Modeling in BIology' NEtwork

EARL - EARL conference; effective application of the R language

ISoP - International Society of Pharmacometrics

PAGANZ - Population Approach Group of Australia and New Zealand

PAGE - Population Appraoch Group in Europe

PharmacoMetrica - PharmacoMetrica workshop

PKUK - Pharmacokinetics (UK)

WCoP - World Conference on Pharmacometrics